What is Redpharm POCT?

Redpharm Point-of-Care Testing (POCT) is an handheld eLab platform, which integrates with nano bio-sensor into a disposable microfluid cartridge, make it possible to accurately analyze all items listed on the catalogue. Redpharm POCT is designed for 2 application aspects, Human use and Veterinary use. Compared with the similar products, it has the advantages of simple operation, high accuracy and good economy. The application of bluetooth transmission technology makes transmission of its diagnostic data more convenient and efficient.


Redpharm POCT with its incomparable real-time diagnostic features, biosensors with carbon nanostructures can be diagnosed within 10 minutes, while central laboratory tests often take hours or even days.



Our portable detection method avoids the transportation of experimental samples, reduces the time consumption and complicated operation. Additionally, it can also improve the mobile care ability to prevent unnecessary ambulance transport and ICU reception, thereby reducing the overall cost. Furthermore, diagnostic equipment of Redpharm POCT is very small, and it can be reduced by at least a third of the volume of the current mainstream POCT portable devices without affecting the performance.


In all hand held mobile diagnostic devices, the accuracy of POCT is comparable to that of the central laboratory, and the testing results are critical to help and support medical professionals to decide the appropriate treatment.

Prompt Diagnosis

Redpharm POCT not only has shorter diagnosis time, higher accuracy, good portability and broad application prospects; Moreover it has a single step diagnosis effect while other POCT devices that do not have, which greatly reduce the link cost.

Broad prospects

Redpharm POCT has compound diagnostic function for various diseases including myocardial infarction and sepsis.

Application field



Sepsis is a life-threatening condition that arises when the body's response to infection causes injury to its own tissues and organs. Common signs and symptoms include fever, increased heart rate, increased breathing rate, and confusion. Sepsis is caused by an immune response triggered by an infection. The risk of death from sepsis is as high as 30%, from severe sepsis as high as 50%, and from septic shock as high as 80%.



Myocardial infarction (MI), commonly known as a heart attack, occurs when blood flow decreases or stops to a part of the heart, causing damage to the heart muscle. Myocardial infarction (MI) refers to tissue death (infarction) of the heart muscle (myocardium). It is a type of acute coronary syndrome, which describes a sudden or short-term change in symptoms related to blood flow to the heart. Unlike other causes of acute coronary syndromes, such as unstable angina, a myocardial infarction occurs when there is cell death, as measured by a blood test of cardiac enzymes such as troponin or CK-MB. Treatment of an MI is time critical. Worldwide, more than 15.9 million myocardial infarctions occurred in 2016.



Infectious disease, also known as transmissible disease or communicable disease, is illness resulting from an infection.Infections are caused by infectious agents including viruses, viroids, prions, bacteria, nematodes such as parasitic roundworms and pinworms, arthropods such as ticks, mites, fleas, and lice, fungi such as ringworm, and other macroparasites such as tapeworms and other helminths. Hosts can fight infections using their immune system. Mammalian hosts react to infections with an innate response, often involving inflammation, followed by an adaptive response. Infectious diseases resulted in 9.2 million deaths in 2013 (about 17% of all deaths).



Heart failure (HF), often referred to as congestive heart failure (CHF), occurs when the heart is unable to pump sufficiently to maintain blood flow to meet the body's needs. Signs and symptoms commonly include shortness of breath, excessive tiredness, and leg swelling. Common causes of heart failure include coronary artery disease including a previous myocardial infarction (heart attack), high blood pressure, atrial fibrillation, valvular heart disease, excess alcohol use, infection, and cardiomyopathy of an unknown cause. Heart failure is a common, costly, and potentially fatal condition. In 2015 it affected about 40 million people globally.



The human immunodeficiency virus (HIV) is a lentivirus (a subgroup of retrovirus) that causes HIV infection and over time acquired immunodeficiency syndrome (AIDS), which was first clinically observed in 1981 in the United States. AIDS is a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. AIDS was first clinically observed in 1981 in the United States.



Stroke is a medical condition in which poor blood flow to the brain results in cell death. There are two main types of stroke: ischemic, due to lack of blood flow, and hemorrhagic, due to bleeding. They result in part of the brain not functioning properly. Signs and symptoms of a stroke may include an inability to move or feel on one side of the body, problems understanding or speaking, feeling like the world is spinning, or loss of vision to one side. Signs and symptoms often appear soon after the stroke has occurred. Stroke was the second most frequent cause of death after coronary artery disease, accounting for 6.3 million deaths (11% of the total). About 3.0 million deaths resulted from ischemic stroke while 3.3 million deaths resulted from hemorrhagic stroke. About half of people who have had a stroke live less than one year.

Detect Myocardial Infarction (MI)


Sepsis Detection

we can

HIV Detection

In the future we can!

Family Doctor

Referral Synergy

Disease Detection

Scientific Education

Market data

up to now
  • In 2014, the domestic medical and health industry was about 3.5 trillion CNY
  • Medical and health industry grows at a rate of 15% per year
  • It is expected to reach 8 trillion CNY by 2020
  • The market size of POCT diagnosis will exceed1 trillion CNY
up to now
  • Global POCT growth was 10.75%
  • The market share of IVD rose to 30%
  • Global markets maintained a compound growth of 9%
  • It will reach $29 billion by 2020


Redpharm POCT is a subdivision of the In Vitro Diagnostic (IVD) device, with the advantages of convenience and fast readiness to achieve quick diagnosis results.


In the face of mobile health care, precision medicine, the rapid development of smart health-care, Redpharm parallel develop disease diagnosis and drug development in parallel, and utilize diagnostic data as the direction of drug research and development people's need is direction of our effort.